RP101

DRUG2 trials

Sponsors

SciClone Pharmaceuticals, Redwood Pharma AB

Conditions

Dry Eye SyndromesPancreatic Cancer

Phase 2

Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine

TerminatedNCT00550004

SciClone PharmaceuticalsPancreatic Cancer

Start: 2007-09-30End: 2009-10-31Target: 153Updated: 2011-06-08

Effects of RP101 in Post-menopausal Women With Dry Eye Syndrome

CompletedNCT03821415

Redwood Pharma ABDry Eye Syndromes

Start: 2019-01-18End: 2019-11-18Updated: 2019-12-20

Related Papers

A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial of a Topical Estradiol Ophthalmic Formulation in Postmenopausal Women with Moderate-to-Severe Dry Eye Disease.

2021-03-129 citations

RP101 (brivudine) binds to heat shock protein HSP27 (HSPB1) and enhances survival in animals and pancreatic cancer patients.

2011-07-2271 citations